UnitedHealth Group Inc (NYSE:UNH)
$ 418.64 -5.61 (-1.32%) Market Cap: 381.06 Bil Enterprise Value: 437.50 Bil PE Ratio: 17.53 PB Ratio: 3.78 GF Score: 93/100

Q4 2024 Unitedhealth Group Inc Earnings Call Transcript

Jan 16, 2025 / 01:45PM GMT
Release Date Price: $510.59 (-6.04%)

Key Points

Positve
  • UnitedHealth Group Inc (UNH) reported 2024 revenues of over $400 billion and adjusted earnings per share of $27.66, meeting their outlook ranges despite unforeseen challenges.
  • The company is making significant investments in digital tools and AI to enhance consumer experience and streamline healthcare processes.
  • Optum Health is expected to serve about 5.4 million value-based care patients in 2025, reflecting a growth of 650,000 over 2024.
  • Optum Rx achieved customer retention exceeding 98% and welcomed a record 750 new clients, demonstrating strong market confidence in their services.
  • UnitedHealth Group Inc (UNH) is committed to full transparency and plans to pass 100% of PBM rebates to clients by 2028, enhancing trust and accountability in drug pricing.
Negative
  • The 2024 medical care ratio was 150 basis points above the original outlook, creating a nearly $5 billion gap due to unexpected challenges.
  • The company faced significant impacts from the Change Healthcare cyberattack and South America business disruptions, contributing to financial strain.
  • There was a notable drop in consumer count within the Optum Health segment, attributed to strategic shifts such as deemphasizing urgent care.
  • The persistently high cost of drugs in the US remains a challenge, with prices significantly higher than in other countries, impacting overall healthcare costs.
  • Medicare Advantage growth was impacted by unusual benefit designs in the market, affecting the expected growth trajectory for 2024.
Operator

Good morning, and welcome to UnitedHealth Group fourth-quarter and full-year 2024 earnings conference call. (Operator Instructions) As a reminder, this call is being recorded.

Here is some important introductory information. This call contains forward-looking statements under US federal securities laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. A description of some of the risks and uncertainties can be found in the reports that we file with the Securities and Exchange Commission, including the cautionary statements included in our current and periodic filings.

This call will also reference non-GAAP amounts. A reconciliation of the non-GAAP to GAAP amounts is available on the Financial and Earnings Reports section of the company's Investor Relations page at www.unitedhealthgroup.com. Information presented on this call is contained in the earnings release we issued this morning and in our Form 8-K

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot